July 2026: Bear Market Survival Strategy — Where Professionals Are Looking
The beginning of July 2026 caught markets in a phase of deep correction. Cryptocurrencies and gold are showing declines, oil is retreating from recent highs, the US dollar is stagnating, and American stock indices are correcting. In such an environment, the key task for an investor is not chasing super-profits, but prudent capital preservation and finding entry points with an attractive risk/reward ratio.
Tokenized Stocks and Semiconductors: Betting on the Technological Foundation
One of the most promising areas I see is the sector of tokenized stocks, especially in the segment of semiconductor companies. This model opens access to global giants through crypto infrastructure almost 24/7, democratizing the stock market. Semiconductors are the "oil" of the modern technological era. Without chips, neither AI, cloud computing, nor autonomous transport are possible. Demand for AI infrastructure solutions and the growth of cloud providers' capital expenditures create a powerful long-term trend. Even against the backdrop of short-term volatility associated with the earnings season, the fundamental cycle remains bullish. Among specific stocks, I highlight Micron, Applied Materials, ARM, and ScanDisk — companies at the forefront of this technological boom.
However, it is important to remember: even strong assets do not grow in a straight line. After powerful rallies, corrections are inevitable. Therefore, I recommend entering positions not all at once, but gradually, using drawdowns for dollar-cost averaging.
Russian Market: Time to Buy "Blood"?
Sentiment in the Russian market can now be described as pessimistic, but, as the old adage goes, the best time to buy is when "blood is flowing." Many quality companies are trading at attractive prices. In addition to the "classic" Sberbank, I am paying attention to HeadHunter, Ozon, and Yandex. These businesses have fallen significantly but have high growth potential when the macroeconomic environment improves. The current situation is a good chance for a long-term entry, although August may offer even deeper levels.
At the same time, the key factor now is not guessing the bottom, but managing risks. I strongly recommend spreading entry over time, not concentrating in a single asset, and keeping a cash reserve to strengthen positions in case of further volatility, especially around Fed decisions. Summer investments should be considered exclusively with a long-term horizon, understanding that drawdowns are possible across all asset classes.
"Triple Protection" Against Devaluation
The main enemy of an investor in 2026 is inflation, which "eats away" the real yield of deposits and bonds. Fixed income in a weakening currency is a losing strategy. This is a rare moment: the market, out of fear of the Fed's tight policy, has sold off precisely those assets that serve as protection against devaluation. Gold has fallen almost 30% from its January peaks, dropping below $4000, and bitcoin has declined 50% from its all-time high. But the reason for the sell-off is temporary, while the growth of national debt and money printing are not going anywhere.
I view the current situation as a global sell-off, not a death sentence. My "triple protection" scheme looks like this: shares of American technology giants around AI (short-term, until record IPOs are "shot off"), gold for the medium term, and cryptocurrency as the most aggressive bet with maximum potential. Bitcoin below the 200-day moving average is a zone where it has lingered briefly in past cycles. It is worth buying via DCA, with a volume that allows you to survive another drawdown without panic. For a ruble portfolio, I prefer not dividend stocks, but shares of exporters and gold miners at their lows.
My conclusion: July 2026 is not a time for aggressive bets, but a period of discipline and endurance. The winner will not be the one who guesses the direction, but the one who can manage risks, gradually accumulating quality assets whose price cannot be printed. The current correction is a discount for the patient.